Check on CHART-1 Phase III Results Outline for C-Cure.

To download the presentation, please click here.

About Celyad

Developing breakthrough pioneering therapies for life-threatening diseases.

Celyad is a biopharmaceutical company, specialized in cell therapy, that is developing landmark technologies aimed at treating severe diseases with poor prognosis. Our scientific approach is inspired by the natural mechanisms that are used by the body to fight disease.

Read more about Celyad

Celyad appoints Philippe Dechamps as General Counsel and Company Secretary

Next News

Celyad appoints Philippe Dechamps as General Counsel and Company Secretary